A complete application in a minute
Tailored resume and cover letter, ready to send.
Moderna Therapeutics Inc. is seeking an experienced Technical Program Manager at our Cambridge, MA campus.
This role sits at the intersection of bioinformatics engineering, computational science, and Quality, coordinating INT and research initiatives while guiding scalable, governed delivery from scoping through deployment. You will work with bioinformatics engineers, scientists, and partners to decompose complex initiatives into actionable plans, manage dependencies, and ensure timely delivery
The Role Joining Moderna means advancing mRNA science to transform medicine. Work with exceptional global teams on a broad pipeline and build a career that makes a real difference for patients. Moderna is strengthening its presence in Cambridge, Massachusetts, home to our global headquarters and a center of mRNA innovation. Working closely with leading universities and research institutions, our Cambridge team advances groundbreaking science that shapes the future of medicine. We welcome talent driven by innovation and committed to improving global health. This individual contributor role will sit at the intersection of bioinformatics engineering, computational science, research, Digital, and Quality, helping Moderna plan and deliver technical initiatives across Individualized Neoantigen Therapy (INT) and research. You will bring structure to complex scientific and engineering work, translating evolving research and operational needs into executable plans while making dependencies, risks, resource constraints, and technical tradeoffs visible. Your work will span exploratory research workflows, shared engineering capabilities, and production bioinformatics systems supporting INT, requiring sound judgment in applying the right level of program management rigor to each environment. You will help teams move complex software and pipeline initiatives from scoping through development, testing, validation, deployment, and sustainable operational support. This is an opportunity to work closely with scientists and engineers building modern bioinformatics capabilities while also increasing your exposure to Generative AI and AI-enabled tools that can strengthen planning, documentation, knowledge capture, workflow analysis, and technical delivery across scientific and engineering programs.
Manage multiple bioinformatics engineering workstreams from initial scoping through development, testing, deployment, and transition to ongoing support. Establish clear deliverables, milestones, accountable owners, dependencies, and acceptance criteria in partnership with scientific and engineering teams.
Partner with team leadership to maintain an integrated view of commitments, available capacity, and competing demands across INT and research. Make resource constraints visible and facilitate decisions around sequencing, scope, priorities, and delivery timelines.
Work closely with bioinformatics engineers, computational scientists, research scientists, and other partners to clarify requirements, distinguish exploratory scientific questions from implementation commitments, and decompose complex initiatives into manageable and measurable deliverables.
Identify infrastructure, data, scientific, engineering, and operational dependencies early. Coordinate mitigation plans, resolve blockers with accountable owners, and expedite decisions with clear options, implications, and tradeoffs.
Build change control, computerized system validation, documentation, review, approval, and evidence-generation activities directly into delivery plans. Partner with System Owners, engineers, Quality colleagues, and validation teams to track readiness and ensure required evidence is available to support release.
Coordinate the iterative development, testing, and evaluation of bioinformatics research pipelines and tools. Enable teams to respond to evolving scientific needs while maintaining clear priorities, reproducibility, appropriate documentation, and visibility into decisions and outcomes.
Establish effective planning, delivery, and review cadences across Bioinformatics Engineering, research, INT program partners, Digital, Quality, and other contributing teams. Capture decisions, clarify ownership, and maintain transparent communication across disciplines.
Provide concise and decision-oriented updates covering delivery status, risks, dependencies, blockers, and decisions required. Use meaningful measures of progress and quality to help scientific, engineering, and program stakeholders make informed choices.
Introduce practical improvements to intake, planning, work tracking, documentation, retrospectives, and delivery governance. Help teams adopt consistent practices while adapting the level of process to the maturity, scientific context, regulatory requirements, and intended use of each system.
Ensure delivery plans account for support ownership, training, operating documentation, transition activities, and follow-up actions so newly delivered capabilities can be operated, supported, and maintained effectively after implementation.
Apply sound judgment when moving between research initiatives where requirements may evolve rapidly and production or GxP systems requiring greater structure, validation, traceability, and release discipline.
Make dependencies, capacity constraints, delivery assumptions, and tradeoffs explicit so engineers, scientists, and leaders can make timely decisions based on a shared understanding of technical and operational realities.
Work alongside Digital, scientific, and engineering colleagues to identify responsible opportunities to use Generative AI and AI-enabled tools to improve technical planning, documentation, knowledge management, workflow efficiency, and collaboration while maintaining appropriate quality and governance standards.
As we build our company, we have always believed an in-person culture is critical to our success. Moderna champions the significant benefits of in-office collaboration by embracing a 70/30 work model. This 70% in-office structure helps to foster a culture rich in innovation, teamwork, and direct mentorship. Join us in shaping a world where every interaction is an opportunity to learn, contribute, and make a meaningful impact. Moderna is a smoke-free, alcohol-free, and drug-free work environment.
Since our founding in 2010, we have aspired to build the leading mRNA technology platform, the infrastructure to reimagine how medicines are created and delivered, and a world-class team. We believe in giving our people a platform to change medicine and an opportunity to change the world. By living our mission, values, and mindsets every day, our people are the driving force behind our scientific progress and our culture. Together, we are creating a culture of belonging and building an organization that cares deeply for our patients, our employees, the environment, and our communities. We are proud to have been recognized as a Science Magazine Top Biopharma Employer, a Fast Company Best Workplace for Innovators, and a Great Place to Work in the U.S. If you want to make a difference and join a team that is changing the future of medicine, we invite you to visit modernatx.com/careers to learn more about our current opportunities.
Moderna is committed to equal employment opportunity and non-discrimination for all employees and qualified applicants without regard to a person's race, color, sex, gender identity or expression, age, religion, national origin, ancestry or citizenship, ethnicity, disability, military or protected veteran status, genetic information, sexual orientation, marital or familial status, or any other personal characteristic protected under applicable law.
Moderna is committed to offering reasonable accommodations to qualified job applicants with disabilities. Any applicant requiring an accommodation in connection with the hiring process and/or to perform the essential functions of the position for which the applicant has applied should contact the Accommodations team at leavesandaccommodations@modernatx.com.
This position may involve access to technology or data that is subject to U.S. export control laws, including the Export Administration Regulations (EAR). As such, employment is contingent upon the applicant’s ability to access export‑controlled information in accordance with U.S. law. Due to the nature of the work and regulatory requirements, only individuals who qualify as U.S. persons (citizens, permanent residents, asylees, or refugees) are eligible for this position. For this role Moderna is unable to sponsor non‑U.S. persons to apply for an export control license.
At Moderna we are pioneering the development of a new class of drugs made of messenger RNA (mRNA). This novel drug platform builds on the discovery that modified mRNA can direct the body’s cellular machinery to produce nearly any protein of interest, from native proteins to antibodies and other entirely novel protein constructs that can have therapeutic activity inside and outside of cells. We have a clear mission to propel the field of mRNA science forward and deliver new medicines to patients and a unique vision for how to achieve this mission. Our Mission: To deliver on the promise of transformative messenger RNA (mRNA) science to bring new medicines to patients. Our Vision: To unlock the potential of mRNA by establishing an ecosystem of teams and partners that will work together to develop the broadest possible array of drugs, across diverse therapeutic areas and routes of administration, for serious diseases that are not treatable today.
Moderna does not accept unsolicited resumes from any source other than directly from candidates. For the protection of all parties involved in the recruiting process, resumes will only be accepted from recruiters/agencies if a signed agreement is in place at the inception of the recruiting effort and authorized for a specified position. Unsolicited resumes sent to Moderna from recruiters/agencies do not constitute any type of relationship between the recruiter/agency and Moderna and do not obligate Moderna to pay fees if we hire from those resumes.